|
⚲
|
| Keyboard |
| Murphy Kimberly M
✚
|
|
|---|---|
| CIK # | 0001810474 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001810474] | |
| 4 | [0001810474] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Oragenics Inc | |
| Murphy Kimberly M | |
| Clarus Therapeutics Holdings Inc | |
| Onconetix Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oragenics Inc OGEN
Non-Employee Director Option (Right to Buy) · derivative
|
2024-09-19 | Grant | 27,083 | $0.00 | |
|
Oragenics Inc OGEN
Common Stock
|
2023-08-08 | Grant | 25,000 | $0.00 | |
|
Oragenics Inc OGEN
Employee Option (Right to Buy) · derivative
|
2022-06-23 | Grant | 800,000 | $0.00 | |
|
Clarus Therapeutics Holdings Inc CRXT
Stock Option (Right to Buy) · derivative
|
2022-06-07 | Grant | 4,805 | $0.00 | |
|
Clarus Therapeutics Holdings Inc CRXT
Common Stock
|
2022-06-07 | Grant | 1,922 | $0.00 | |
|
Onconetix Inc BWV
Stock Option · derivative
|
2022-05-04 | Grant | 4,655 | $0.00 | |
|
Oragenics Inc OGEN
Non-Employee Director Option (Right to Buy) · derivative
|
2021-12-16 | Grant | 75,000 | $0.00 | |
|
Clarus Therapeutics Holdings Inc CRXT
Common Stock
|
2021-12-12 | Grant | 3,844 | $0.00 | |
|
Clarus Therapeutics Holdings Inc CRXT
Stock Option (Right to Buy) · derivative
|
2021-12-12 | Grant | 9,610 | $0.00 | |
|
Oragenics Inc OGEN
Non-Employee Director Option (Right to Buy) · derivative
|
2021-02-18 | Grant | 160,000 | $0.00 | |
|
Oragenics Inc OGEN
Non-Employee Director Option (Right to Buy) · derivative
|
2020-05-01 | Grant | 138,664 | $0.00 |